|
業務類別
|
Biotechnology |
|
業務概覽
|
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. |
| 公司地址
| 1 Casper Street, Danbury, CT, USA, 06810 |
| 電話號碼
| +1 818 661-5000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.mannkindcorp.com |
| 員工數量
| 592 |
| Dr. David B. Thomson, J.D.,PhD |
Executive Vice President, General Counsel and Secretary |
美元 520.75K |
07/04/2026 |
| Dr. Stuart A. Tross, PhD |
Executive Vice President, Human Resources |
美元 438.71K |
07/04/2026 |
| Mr. Michael E. Castagna, Pharm.D. |
Director and Chief Executive Officer |
美元 789.44K |
07/04/2026 |
| Mr. Christopher B. Prentiss |
Chief Financial Officer and Principal Accounting Officer |
美元 470.09K |
07/04/2026 |
| Mr. Sanjay R. Singh, M.B.A. |
Executive Vice President, Technical Operations |
-- |
07/04/2026 |
| Mr. Dominic Marasco |
President, Endocrine Business Unit |
美元 447.60K |
07/04/2026 |
| Dr. Ajay Ahuja, M.B.A.,M.D. |
Executive Vice President and Chief Medical Officer |
-- |
07/04/2026 |
|
|
| Mr. Anthony C. Hooper |
Independent Director |
07/04/2026 |
| Dr. Michael A. Friedman M.D. |
Independent Director |
07/04/2026 |
| Mr. Ronald J. Consiglio |
Independent Director |
07/04/2026 |
| Dr. James S. Shannon, M.D.,M.R.C.P. |
Chairman of the Board |
07/04/2026 |
| Mr. Michael E. Castagna, Pharm.D. |
Director and Chief Executive Officer |
07/04/2026 |
| Mr. Steven B. Binder |
Director |
07/04/2026 |
| Ms. Christine A. Mundkur |
Independent Director |
07/04/2026 |
| Ms. Jennifer Grancio |
Independent Director |
07/04/2026 |
| Dr. Sabrina Kay, PhD |
Independent Director |
07/04/2026 |
|
|
|
|
